Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Radiotherapy for Atypical Teratoid/Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR).

13/04/2023
/ Publications
/
Chemotherapy
Dosimetry

This study evaluated 68 patients with atypical teratoid/rhabdoid tumors (ATRT) treated with surgery (65% initial gross total resection or GTR), chemotherapy (60...

Gastrointestinal bleeding/ulcer among paediatric cancer patients after proton beam therapy.

13/06/2023
/ Publications
/
Reirradiation
Chemotherapy

This study analyzed 124 patients who underwent proton therapy with gastrointestinal tract involved in the irradiated field. The study reported gastrointestinal...

Neurocognitive outcomes in pediatric brain tumors after treatment with proton versus photon radiation: a systematic review and meta-analysis.

13/08/2023
/ Publications

Based on 10 studies including a total 630 patients, this review reported that proton therapy produced significantly higher scores for most analyzed...

Proton therapy for pediatric diencephalic tumors.

13/05/2023
/ Publications
/
Toxicity

Tumors arise in the diencephalon including optic pathway/hypothalamic glioma, craniopharyngioma, germ cell tumors, and pituitary adenomas which tend to be low...

Proton Therapy Mediates Dose Reductions to Brain Structures Associated with Cognition in Children with Medulloblastoma.

13/11/2023
/ Publications
/
Dosimetry

This study evaluated dosimetric and cognitive data from 75 patients with medulloblastoma treated with proton (n=36) and photon (n=39). Significant dose...

MGH’s 20 Years Treating with Protons and their Important Role in Pediatrics

29/09/2021
/ Podcast

September marks Childhood Cancer Awareness Month, so this episode will focus on pediatric cancer treatment and the many ways proton therapy can benefit children...

Young Adult Populations Face Yet Another Barrier to Care with Insurers: Limited Access to Proton Therapy.

16/08/2021
/ Publications
/
Toxicity
Secondary cancer

Young adult patients (n = 68/143, 48%) were significantly less likely to receive initial approval compared with pediatric patients (n = 139/141; 99%) (P < .001)...

Parallel explorations in LA-NSCLC: Chemoradiation dose-response optimisation considering immunotherapy and cardiac toxicity sparing.

29/10/2024
/ Publications

Published in the Green Journal, this study used dose-response models for predicting outcomes of chemoradiation (CRT) plus immune checkpoint blockade (ICB) for...

Sparing of the heart facilitates recovery from cardiopulmonary side effects after thoracic irradiation.

29/10/2024
/ Publications

Published in the Red Journal, this study from the Groningen group reported persistent reduction in cardiopulmonary function caused by radiation exposure of the...

A Pilot Trial of Proton Based Cardiac Sparing Accelerated Fractionated RadioTherapy in Unresectable Non-Small Cell Lung Cancer with Extended Durvalumab Therapy (PARTICLE-D).

29/10/2024
/ Publications

This phase I dose-escalation study by the group of Cleveland Medical Center, Ohio, reported severe treatment related toxicity. A total of 7 patients with stage...